ترودو : نأمل في بداية الإنتاج محليا في أغسطس
خالد سلامة – أخبار كندا
أعلن جاستن ترودو رئيس وزراء كندا عن توقيع اتفاق مع شركة نوفافاكس تسمح بمقتضاه تلك الشركة بإنتاج لقاحات كورونا في واحدة من المصانع التي سيتم تشييدها والانتهاء منها خصيصا لهذا الغرض ويجرى العمل فيها حاليا في مونتريال
وأوضح ترودو إنه يأمل أن تبدأ تلك المصانع في الانتاج بحلول شهر أغسطس في الصيف المقبل ولكنه لم يؤكد إن كان ذلك التاريخ قاطعا أم
كما أوضح ترودو أنه يأمل أن يتم تطعيم عشرة مليون كندي قريبا فيما يطمح أن يكون التطعيم متوافرا للجميع بحلول سبتمبر
Prime Minister Justin Trudeau announced today a plan to produce millions of COVID-19 shots at a plant in Montreal starting this summer, securing a domestic supply of vaccines as the global market contends with delivery delays and protectionist measures.
The National Research Council-owned Royalmount facility will churn out tens of millions of doses of the product developed by Maryland-based Novavax, Trudeau said. That company submitted its vaccine to Health Canada for regulatory approval last Friday.
“This is a major step forward to get vaccines made in Canada, for Canadians…. We need as much domestic capacity for vaccine production as possible,” Trudeau said. “We won’t rest until every Canadian who wants a vaccine has received one.”
Novavax has said its protein-based COVID-19 vaccine product produced an efficacy rate of 89.3 per cent in late stage clinical trials, with strong protection against the strain of the virus first reported in the U.K., which has shown to be more resistant to other vaccine candidates.
Canada agreed to purchase shots from Novavax — a biotechnology company that has been at the forefront of developing new vaccines against influenza — last August. The government has since upped that purchase agreement with a commitment to buy at least 52 million doses of the two-dose product.
Who
